ESR1 and neoplasm: Importantly, the differential expression of the selected proteins reflects key clinical parameters defining breast cancer subtypes: ER status (INPP4B; Figure 3B); tumor grade (CDK1; Figure 3C); and HER2 status (ERBB2; Figure 3D).